Double Chamber Prefilled Syringes Market

Global Market Study on Double Chamber Prefilled Syringes: Demand for highly efficient parenteral drug delivery modes to drive market expansion

Double Chamber Prefilled Syringes Market Segmented By Glass and Plastic Material with Hemophilia, Schizophrenia, Diabetes, Erectile Dysfunction, Endometriosis, Precocious Puberty Indication

  • June-2022
  • PMRREP29257
  • 275 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Double Chamber Prefilled Syringes Market Outlook (2022 - 2029)

The use of double chamber prefilled syringes reduces the hazards associated with drug reconstitution and incorrect dosage. With a strong emphasis on safety, double chamber prefilled syringes allow the drug to be injected to the desired depth without the need for supervision. Apart from hospitals and clinics, the home-care segment is also emerging and is expected to drive demand for double chamber prefilled syringes. The increasing need for highly efficient parenteral drug delivery modes is the major factor driving the growth of the Double Chamber Prefilled Syringes Market. The Global Double Chamber Prefilled Syringes market is expected to have a CAGR of 9.20% from USD 1,946.40 Million in 2022 to USD 3,595.70 Million in 2029.

Double Chamber Prefilled Syringes Market Size (2022)

US$ 1,946.40 Mn

Projected Market Value (2029)

US$ 3,595.70 Mn

Global Market Growth Rate (2022 - 2029)

9.20% CAGR

Share in parent market

13.70%

Find Out More about the Report Coverage

Companies

  • Pfizer Inc.
  • Biosciences, Inc.
  • Ypsomed AG
  • Otsuka America Pharmaceutical, Inc.
  • Credence MedSystems, Inc.
  • Vetter Pharma International GmbH
  • MAEDA INDUSTRY Co., Ltd.
  • AstraZeneca plc
  • AbbVie Inc.
  • Nipro Corporation
  • SCHOTT AG

Double Chamber Prefilled Syringes Market Demand Analysis (2014-2021) v/s Market Outlook (2022 - 2029)

The global market for Double Chamber Prefilled Syringes is likely to grow rapidly in the coming years due to its ease of use, high efficiency and accuracy along with the increasing need for highly efficient parenteral drug delivery modes. The global Double Chamber Prefilled Syringes market is expected to grow rapidly throughout the forecast period.

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Key Drivers to the Double Chamber Prefilled Syringes Market

  • Increased Sterility, Safety, and Accuracy

Drug delivery methods have a significant impact on the efficacy of drugs. Double chamber syringe technology provides extremely efficient drug usage through accurate product composition. Double-chamber syringes are specially intended for the delivery of extremely sensitive drugs. Double chamber prefilled syringes are emerging as the best and most preferred drug delivery mode due to their high efficiency, accuracy, and safety in administering lyophilized and liquid formulations.

double-chamber-prefilled-syringes-market

  • Ease of Use

As drug delivery and time-consuming operations such as cleaning, siliconization, and sterilizing have become a long-standing concern in healthcare facilities, the demand for ready-to-use syringes led to the development of double chamber prefilled syringes. In return for its efficiency and ease of use, the injection of the drug with a little 'twist and push' began receiving the appropriate traction, and the trend is anticipated to continue in the coming years.

  • Extensive Research and Development Initiatives

Extensive research and development efforts have enabled double chamber prefilled syringes to surpass their competition, with the ability to reduce medication waste and provide a longer shelf life. With severe quality filters imposed by regulatory bodies, manufacturers are working hard to make safe double chamber prefilled syringes. Increasing research and development initiatives for Double Chamber Prefilled Syringes are expected to drive market growth over the forecast period.

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

Impact of COVID-19 on Double Chamber Prefilled Syringes Market

The COVID-19 outbreak had a significant impact on the market for Double Chamber Prefilled Syringes. During the pandemic, there was a considerable rise in the use of Double Chamber Prefilled Syringes, because of an increase in drug delivery for treating millions of people suffering from covid-19. The demand for Double Chamber Prefilled Syringes increased significantly after the vaccines were developed as billions were vaccinated with the use of these syringes.

Explore Persistence Market Research’s expertise in promulgation of the business !

Competitive Landscape

The Double Chamber Prefilled Syringes Market is highly fragmented with numerous players catering to individual countries and only a handful of companies having an international footprint. The major players in the Double Chamber Prefilled Syringes market are focusing on developing and launching new products to increase their product offerings. To increase their global market presence, these companies are increasing R&D efforts, and are also engaging in partnerships, mergers and acquisitions.

Double Chamber Prefilled Syringes Market Industry Report Scope

Attribute

Details

Forecast Period

2022 - 2029

Historical Data Available for

2014-2021

Market Analysis

US$ Mn/Bn for Value

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Key Countries Covered

  • U.S.
  • Canada
  • Germany
  • Italy
  • France
  • U.K.
  • Spain
  • Russia
  • India
  • China
  • Japan
  • UAE
  • Australia

Key Market Segments Covered

By Product Type

Key Companies Profiled

  • Pfizer Inc.
  • Biosciences, Inc.
  • Ypsomed AG
  • Otsuka America Pharmaceutical, Inc.
  • Credence MedSystems, Inc.
  • Vetter Pharma International GmbH
  • MAEDA INDUSTRY Co., Ltd.
  • AstraZeneca plc
  • AbbVie Inc.
  • Nipro Corporation
  • SCHOTT AG

Customization & Pricing

Available upon Request

Double Chamber Prefilled Syringes Market Categorization

Double Chamber Prefilled Syringes Market by Product Type

  • <1.0 mL
  • 1.0 – 2.5 mL
  • 2.5 – 5.0 mL
  • >5 mL

Double Chamber Prefilled Syringes Market by Material

  • Plastic
  • Glass

Double Chamber Prefilled Syringes Market by Application

  • Liquid/Liquid
  • Liquid/Powder
  • Liquid/Lyophilisate

Double Chamber Prefilled Syringes Market by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Double Chamber Prefilled Syringes Market by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

- FAQs -

In 2022, the Double Chamber Prefilled Syringes Market stands at USD 1,946.40   million, and it is expected to reach USD 1,595.70 million by 2029 at a CAGR of 9.20%.

Double Chamber Prefilled Syringes Market exhibited a CAGR of 8.50% between 2014 and 2021.

Increased sterility, safety, and accuracy of double chamber prefilled syringes are the key factors driving the growth of the market.

Pfizer Inc., Biosciences Inc., Ypsomed AG, and Otsuka America Pharmaceutical Inc, are among the top players in the market.

Recommendations

Insulin Delivery Device Market

The global insulin delivery devices market is on the spike, and is estimated to climb up in terms of revenues, reaching US$ 14.09 Bn by 2020.

Next Generation Iv Infusion Pumps Market

Global Next-generation IV Infusion Pumps Market study report offers comprehensive data and information about the important market dynamics & growth parameters.

Injectable Nanomedicines Market

Injectable nanomedicines market is expected to witness significant growth with CAGR pegged at 8.1% through 2026. Manufacturers of injectable nanomedicines are targeting chronic diseases and cancers..

Autogenous Vaccines Market

The global autogenous vaccines market is expected to progress at a healthy CAGR of 5.5% over the 2021-2031 assessment period, with demand being the highest from livestock farming companies..

Our Clients

Our Clients